However, IFN-induced gene expression was found to be increased in a clinical trial, although RNase1 treatment improved patient fatigue (10), indicating that RNase1 has the potential to stimulate autoimmune responses in SS. The gene discussed is RNASE1; the disease is synovial sarcoma.